Analysts forecast that Centene Corp (NYSE:CNC) will announce $13.17 billion in sales for the current quarter, according to Zacks. Six analysts have issued estimates for Centene’s earnings, with estimates ranging from $12.65 billion to $13.74 billion. Centene reported sales of $11.72 billion in the same quarter last year, which would suggest a positive year-over-year growth rate of 12.4%. The company is scheduled to report its next earnings report on Tuesday, April 24th.
On average, analysts expect that Centene will report full year sales of $13.17 billion for the current financial year, with estimates ranging from $60.63 billion to $61.55 billion. For the next year, analysts expect that the business will post sales of $67.80 billion per share, with estimates ranging from $66.75 billion to $69.96 billion. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Centene.
Centene (NYSE:CNC) last issued its earnings results on Tuesday, February 6th. The company reported $0.97 EPS for the quarter, beating the Zacks’ consensus estimate of $0.94 by $0.03. Centene had a net margin of 1.71% and a return on equity of 13.68%. The business had revenue of $12.81 billion for the quarter, compared to the consensus estimate of $12.25 billion. During the same quarter last year, the firm posted $1.19 EPS. The business’s revenue for the quarter was up 7.5% compared to the same quarter last year.
Centene (CNC) opened at $100.30 on Tuesday. Centene has a one year low of $65.03 and a one year high of $112.42. The company has a quick ratio of 0.93, a current ratio of 0.93 and a debt-to-equity ratio of 0.68. The company has a market cap of $17,993.49, a price-to-earnings ratio of 20.41, a PEG ratio of 0.99 and a beta of 0.76.
In other Centene news, EVP Keith H. Williamson sold 5,000 shares of the firm’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $100.11, for a total transaction of $500,550.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Robert K. Ditmore sold 8,750 shares of the firm’s stock in a transaction on Monday, January 8th. The stock was sold at an average price of $104.30, for a total transaction of $912,625.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,500 shares of company stock valued at $3,311,613. 3.00% of the stock is owned by company insiders.
A number of hedge funds have recently made changes to their positions in CNC. Focused Wealth Management Inc grew its holdings in Centene by 900.0% during the 4th quarter. Focused Wealth Management Inc now owns 1,000 shares of the company’s stock worth $101,000 after acquiring an additional 900 shares in the last quarter. Financial Gravity Companies Inc. acquired a new position in Centene during the 4th quarter worth $112,000. We Are One Seven LLC acquired a new position in Centene during the 4th quarter worth $114,000. Harel Insurance Investments & Financial Services Ltd. acquired a new position in Centene during the 4th quarter worth $131,000. Finally, Tower Research Capital LLC TRC acquired a new position in Centene during the 4th quarter worth $145,000. 90.53% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: This story was published by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of US and international copyright and trademark law. The correct version of this story can be accessed at https://www.americanbankingnews.com/2018/03/13/centene-corp-cnc-expected-to-post-quarterly-sales-of-13-17-billion.html.
Centene Company Profile
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.